Glaxo Agrees to Misdemeanor Plea, Will Pay $3B in Record Health Care Fraud Settlement with Feds

A British drug manufacturer has agreed to pay $1 billion in criminal fines and $2 billion in civil fines and revamp its compliance procedures to settle wide-ranging allegations by U.S. officials of wrongdoing in the company's marketing and promotion of its products over a period of nearly a decade. The payment to be made by GlaxoSmithKline Plc represents both the largest health-care fraud...